{
  "id": 13961513,
  "title": "Essix Biosciences Acquires 14 lakh Equity Shares Of Ind-Swift Laboratories",
  "url": "https://urgent.news/2026/10/12/essix-biosciences-acquires-14-lakh-equity-shares-of-ind-swift",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-12T12:21:25.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/essix-biosciences-acquires-14-lakh-equity-shares-of-ind-swift-laboratories"
  },
  "original_language": "en",
  "account": "Mumbai: Essix Biosciences Limited, a promoter-owned entity of Ind-Swift Laboratories Limited, acquired 14 lakh equity shares from the target company on October 8, 2026. The transaction involved converting fully convertible warrants, increasing Essix Biosciences' direct voting rights in Ind-Swift Laboratories. Shareholding Before Acquisition Essix Biosciences Limited held 3,28,82,521 shares, or 37.81% of total share/voting capital and 35.00% of total diluted share/voting capital. The promoters, including Essix Biosciences, collectively owned 4,43,34,278 shares, or 42.93% of total share/voting capital and 47.18% of total diluted share/voting capital. Shareholding After Acquisition After the acquisition, Essix Biosciences' direct holding grew to 3,42,82,521 shares, or 38.80% of total share/voting capital and 36.48% of total diluted share/voting capital. The promoters and promoter group retained 4,43,34,278 shares, or 43.84% of total share/voting capital and 47.18% of total diluted share/voting capital. Capital Structure Impact The equity share capital of Ind-Swift Laboratories Limited rose from ₹86,96,15,580 to ₹88,36,15,580, consisting of 8,69,61,558 and 8,83,61,558 shares of ₹10 each, respectively. The total diluted share/voting capital after the acquisition reached ₹93,96,15,580, made up of 9,39,61,558 equity shares of ₹10 each.",
  "summary": "Mumbai: Essix Biosciences Limited, an acquirer belonging to the promoter group of Ind-Swift Laboratories Limited, has acquired 14 lakh equity shares of the target company. The acquisition took place on October 8, 2026, through the conversion of fully convertible warrants . Acquisition Details The acquisition involved 14 lakh equity shares, each with a face value of ₹10, as a result of converting…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}